1795 papers
Neuroscience explores the intricate machinery of the brain and nervous system, seeking to understand how we think, feel, and move. From the microscopic dance of individual neurons to the complex networks that shape our memories and behaviors, this field peels back the layers of our biological selves to reveal the origins of consciousness and disease.
At Gist.Science, we bring these discoveries directly from bioRxiv, the leading preprint server for biological sciences, to a broader audience. We process every new neuroscience preprint as it is uploaded, transforming dense academic manuscripts into clear, plain-language explanations alongside detailed technical summaries. This ensures that both curious readers and specialists can stay current with the latest breakthroughs before they are formally published.
Below are the latest neuroscience papers we have processed from bioRxiv, offering fresh insights into the workings of the mind.
This study demonstrates that inhibitory projections from the thalamic reticular nucleus dynamically reorganize sensory thalamic population activity to align neuronal coding with learned behavioral value, a mechanism essential for adaptive perception that goes beyond simple sensory gating.
This study systematically compares color representations across self-supervised, supervised, and CLIP-trained deep neural networks using Gromov-Wasserstein Optimal Transport to demonstrate that while early layers of all paradigms align with human perception, only CLIP maintains this structural congruence at the output, enabling reliable predictions of human color perception across vast, previously unexplored color spaces.
This study demonstrates that while single-neuron visual responses in the superior colliculus (SC) predict saccadic reaction times better than those in the primary visual cortex (V1), the predictive power of SC responses improves significantly with the addition of simultaneously recorded neurons, whereas V1 responses show little improvement except for dark stimuli, suggesting that SC visual signals are functionally reformatted from V1 inputs to better drive motor behavior.
This study reveals that the thirteen-lined ground squirrel's hibernation-induced neuroprotection against optic nerve injury is driven by metabolic reprogramming and the release of exosomes containing cargo that stabilizes cellular stress responses, offering a potential blueprint for new glaucoma therapies.
This study reveals that a Parkinson's-associated Synj1 mutation causes selective dystrophic axonal dilations with massive plasma membrane infoldings in dopaminergic neurons, indicating a catastrophic failure of endocytic mechanisms that leads to dopamine release deficits.
This study demonstrates that the purported 5-HT4 receptor agonist RS67333 modulates striatal acetylcholine and dopamine release not through 5-HT4 receptor activation, but by inhibiting acetylcholinesterase, thereby extending acetylcholine lifetime and indirectly influencing dopamine via nicotinic receptors.
This study demonstrates that prolonged social isolation in adult mice impairs hippocampal-dependent pattern separation by upregulating miR-30e-5p in the ventral hippocampus, which subsequently downregulates the target gene Neurod1, without inducing overt anxiety or depression-like behaviors.
This study reveals that activity-dependent formation and autophagic clearance of lipid droplets in neuronal compartments are essential mechanisms for maintaining synaptic integrity and proper motor function.
This study identifies the LMO7-BAG5 complex as a critical inhibitor of tau degradation, demonstrating that disrupting this interaction via genetic knockdown, a designed peptide, or repurposed drugs like Telmisartan and MPA-2 effectively reduces pathogenic tau and rescues memory deficits in Alzheimer's disease models.
Using the EFAD mouse model, this study demonstrates that anti-amyloid immunotherapy triggers APOE4-specific increases in glial reactivity, perivascular immune activation, and ARIA-like microhemorrhages due to unique vascular susceptibility, highlighting critical immunological targets for mitigating treatment risks in APOE4 carriers.